2-amino-N-benzyl-6H-pyrazolo[3,4-g][1,3]benzothiazole-8-carboxamide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡唑类
• 英文名称: 2-amino-N-benzyl-6H-pyrazolo[3,4-g][1,3]benzothiazole-8-carboxamide
• 化学式: C₁₆H₁₃N₅OS
• 分子量: 323.4
• InChiKey: FUZFXWRPHAXNJB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  23
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  125
• 氢给体数：
  3
• 氢受体数：
  5

文献信息

• 3-(Carbonyl) 1h-indazole compounds as cyclin dependent kinases (cdk) inhibitors
  申请人：Berdini Valerio

  公开号：US20060135516A1

  公开（公告）日：2006-06-22

  The invention provides a compound of the formula (I): wherein E is O, S, or NH; G is selected from hydrogen; carbocyclic and heterocyclic groups having from 3 to 12 ring members; and acyclic C 1-8 hydrocarbyl groups optionally substituted; provided that E—G is not OH or SH and further provided that E—G does not contain the group O—O; two adjacent moieties selected from R 3 , R 4 , R 5 and R 6 , together with the carbon atoms to which they are attached, form a fused heterocyclic group having from 5 to 7 ring members and 1, 2 or 3 ring heteroatoms selected from N, O and S; and the other two moieties selected from R 3 , R 4 , R 5 and R 6 are the same or different and are each as defined in the description. The Invention also provides compounds of the formula (I) for use as inhibitors of cyclin dependent kinases and for use in the treatment of disease states and conditions mediated by cyclin dependent kinases.

  本发明提供了式（I）的化合物：其中E为O，S或NH；G选择自氢；具有3至12个环成员的碳环和杂环基团；以及可选地被取代的C1-8烷基基团；前提是E-G不是OH或SH，并且进一步提供E-G不包含O-O基团；从R3、R4、R5和R6中选择的两个相邻基团，与它们附着的碳原子一起形成具有5至7个环成员和1、2或3个N、O和S杂原子的融合杂环基团；而从R3、R4、R5和R6中选择的另外两个基团相同或不同，并且每个基团如描述中所定义。本发明还提供了式（I）的化合物，用作细胞周期依赖性激酶的抑制剂，并用于治疗由细胞周期依赖性激酶介导的疾病状态和病情。
• 3-(CARBONYL) 1H-INDAZOLE COMPOUNDS AS CYCLIN DEPENDENT KINASES (CDK) INHIBITORS
  申请人：Astex Technology Limited

  公开号：EP1546156A1

  公开（公告）日：2005-06-29
• [EN] 3-(CARBONYL) 1H-INDAZOLE COMPOUNDS AS CYCLIN DEPENDENT KINASES (CDK) INHIBITORS<br/>[FR] COMPOSES 3-(CARBONYL) 1H-INDAZOLE UTILISES EN TANT QU'INHIBITEURS DE KINASES CYCLINE-DEPENDANTES (CDK)
  申请人：ASTEX TECHNOLOGY LTD

  公开号：WO2004014922A1

  公开（公告）日：2004-02-19

  The invention provides a compound of the formula (I): wherein E is O, S, or NH; G is selected from hydrogen; carbocyclic and heterocyclic groups having from 3 to 12 ring members; and acyclic C1-8 hydrocarbyl groups optionally substituted; provided that E-G is not OH or SH and further provided that E-G does not contain the group O-O; two adjacent moieties selected from R3, R4, R5 and R6, together with the carbon atoms to which they are attached, form a fused heterocyclic group having from 5 to 7 ring members and 1, 2 or 3 ring heteroatoms selected from N, O and S; and the other two moieties selected from R3, R4, R5 and R6.are the same or different and are each as defined in the description. The Invention also provides compounds of the formula (I) for use as inhibitors of cyclin dependent kinases and for use in the treatment of disease states and conditions mediated by cyclin dependent kinases.